CoxyPet® — Topical (via the skin) pain control for animals

CoxyPet® is Auxesis Pharma’s portfolio for topical (via the skin) pain-control treatment in animals, developed to treat pain and irritation directly on the skin.

The medicine is based on the same scientific foundation as our medicines for humans, but adapted for animals’ skin, physiology and needs.

Instead of systemic treatments that affect the whole body, CoxyPet® offers a local, precise and gentle alternative for dogs, horses and livestock.

CoxyPet product

What is CoxyPet®?

CoxyPet® is based on Auxesis’ stable, liquid form of acetylsalicylic acid.

Today there is no other OTC medicine that removes pain and irritation in the skin in a fast and targeted way. Available products often provide a cooling or temporary effect — but the effect wears off quickly and application must be repeated.

For the animal, that means:

  • reduced swelling
  • reduced irritation
  • faster control of skin pain
  • lower risk of side effects

Broad areas of use.

Our technology effectively addresses a range of common yet painful conditions.

Different types of skin pain:

Pets

Fast topical pain-control treatment for dogs and cats for minor injuries, irritation or inflammation.

Horses and livestock

Topical pain-control treatment for local injuries, insect bites and skin irritation.

For veterinarians

Scientifically developed, clinically anchored medicines for professional use.

Why topical (via the skin) pain-control treatment for animals?

Pain in animals rarely appears like it does in humans. It is often hidden behind changed behavior, restlessness, licking or avoidance of touch.

Even though much of the pain is in the skin, it is often treated with systemic medicines such as NSAIDs or antibiotics, which can cause side effects — especially with long-term use. This makes topical treatment an important new alternative.

Topical pain-control treatment penetrates the skin and acts directly on the affected area. This makes treatment more precise and often gentler than traditional options.

This treatment principle makes it possible to:

  • treat pain where it occurs
  • reduce the need for systemic medicines
  • avoid unnecessary burden on the animal’s body
  • deliver fast, local effect for skin-related pain
  • offer a gentler option for recurring issues
Animals and skin

Safety and research

CoxyPet® is developed in Sweden according to established routines for veterinary development. Work includes, among other things:

  • Toxicology
  • Skin penetration studies
  • Stability testing
  • Effect studies
  • Safety assessments for young and older animals
Veterinary topical treatment
CoxyPet products

Concept packaging design. Final product may differ and is not yet approved for sale.

Discover ASA.P® — Topical (via the skin) pain control for skin pain

ASA.P® is Auxesis Pharma’s topical medicine for skin pain, developed for fast, local treatment of irritation, inflammation and pain directly in the skin.

ASA.P skin image
?

Ask Auxesis

Digital customer support

Hello! I can help you with common questions about Auxesis Pharma, products, news and shareholder information. What would you like to know?